Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Sarcopenia

Locally Advanced Non-small Cell Lung Cancer

Carcinoma, Hepatocellular

Multiple Myeloma

Carcinoma, Non-Small-Cell Lung

Pancreatic Ductal Adenocarcinoma

Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Brain Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

Objective Response Rate

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Uveal Melanoma, Neoplasm Metastasis

Neoplasm Metastasis, Stomach Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Carcinoma, Ovarian Epithelial

Carcinoma, Hepatocellular

Advanced Pancreatic Cancer

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Recurrence

Lung Neoplasms

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Cholangiocarcinoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma

Clinical Trials

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

CAREMM-2305

STARTNEWERA-OM

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

TREATMENT

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

I-STOP

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Real-world Study for Patients With Advanced Hepatobiliary Tumors

TRAILOCLORI01

QUASAR

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

RECORD

Thermal Ablation Followed by Immunotherapy for HCC

DreaminLMBC

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

LBA-PI

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

ACCORD

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors